Ligand Pharmaceuticals Incorporated (LGND)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | |
| DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided information, Ligand Pharmaceuticals Incorporated's days of sales outstanding (DSO) data for the years ranging from December 31, 2020, to December 31, 2024, is not disclosed. This lack of specific DSO figures hinders the ability to assess the average number of days it takes for the company to collect payments from its customers for sales made. As DSO is a crucial indicator of a company's efficiency in managing accounts receivable, the absence of this data limits the ability to evaluate Ligand Pharmaceuticals' performance in this aspect. It is recommended to consider obtaining or calculating this information to gain insights into the company's accounts receivable management effectiveness.
Peer comparison
Dec 31, 2024